Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. | 27387658 | Balekian AA, Tanner NT, Fisher JM, Silvestri GA, Gould MK | Ann Am Thorac Soc | 2016 | NLST |
| Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration. | 27330355 | Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC | Curr Oncol | 2016 | NLST |
| Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network. | 27664507 | Petousis P, Han SX, Aberle D, Bui AA | Artif Intell Med | 2016 | NLST |
| Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST). | 27925181 | Goldwasser DL | Int. J. Cancer | 2016 | NLST |
| The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort. | 27740906 | White CS, Dharaiya E, Campbell E, Boroczky L | Radiology | 2016 | NLST |
| Evaluating Long-Term Outcomes via Computed Tomography in Lung Cancer Screening | Dongfeng Wu, Ruiqi Liu, Beth Levitt, Tom Riley, Kathy B. Baumgartner | J Biom Biostat | 2016 | NLST | |
| Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial. | 27836710 | Lewicki P, Shoag J, Golombos DM, Oromendia C, Ballman KV, Halpern JA, Stone BV, O'Malley P, Barbieri CE, Scherr DS | J. Urol. | 2016 | PLCO |
| Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel. | 27810449 | Kim EH, Andriole GL, Crawford ED, Sjoberg DD, Assel M, Vickers AJ, Lilja H | J. Urol. | 2016 | PLCO |
| Reevaluating PSA Testing Rates in the PLCO Trial. | 27144870 | Shoag JE, Mittal S, Hu JC | N. Engl. J. Med. | 2016 | PLCO |
| Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 27149646 | Bradley MC, Black A, Freedman AN, Barron TI | Cancer | 2016 | PLCO |
| Lethal Prostate Cancer in the PLCO Cancer Screening Trial. | 27166670 | Shoag J, Mittal S, Halpern JA, Scherr D, Hu JC, Barbieri CE | Eur. Urol. | 2016 | PLCO |
| Active follow-up versus passive linkage with cancer registries for case ascertainment in a cohort. | 27687075 | Pinsky PF, Yu K, Black A, Huang WY, Prorok PC | Cancer Epidemiol | 2016 | PLCO |
| The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource. | 27635065 | Zhu CS, Huang WY, Pinsky PF, Berg CD, Sherman M, Yu KJ, Carrick DM, Black A, Hoover R, Lenz P, Williams C, Hawkins L, Chaloux M, Yurgalevitch S, Mathew S, Miller A, Olivo V, Khan A, Pretzel SM, Multerer D, Beckmann P, Broski KG, Freedman ND | Cancer Epidemiol. Biomarkers Prev. | 2016 | PLCO |
| Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up. | 27615399 | Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E, Gohagan J, Berg CD, Prorok PC | Gynecol. Oncol. | 2016 | PLCO |
| Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment. | 27009534 | Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, Graubard BI, Berndt SI, Hofmann JN, Purdue MP, Moore LE, Colt JS | Int. J. Cancer | 2016 | PLCO |
| Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients. | 26757251 | Wang Y, Liu H, Ready NE, Su L, Wei Y, Christiani DC, Wei Q | Int. J. Cancer | 2016 | PLCO |
| The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 26611771 | Shoaibi A , Rao GA , Cai B , Rawl J , Hébert JR | Ann Epidemiol | 2016 | PLCO |
| Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. | 26586795 | Phipps AI, Passarelli MN, Chan AT, Harrison TA, Jeon J, Hutter CM, Berndt SI, Brenner H, Caan BJ, Campbell PT, Chang-Claude J, Chanock SJ, Cheadle JP, Curtis KR, Duggan D, Fisher D, Fuchs CS, Gala M, Giovannucci EL, Hayes RB, Hoffmeister M, Hsu L, J… | Carcinogenesis | 2016 | PLCO |
| CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. | 26766742 | Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Figueiredo JC, Harrison TA, Jiao S, Brenner H, Casey G, Hudson TJ, Thornquist M, Le Marchand L, Potter J, Slattery ML, Zanke B, Baron JA, Caan BJ, Chanock SJ, Berndt SI, Stelling D, Fu… | Br. J. Cancer | 2016 | PLCO |
| Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants. | 27379672 | Du M, Jiao S, Bien SA, Gala M, Abecasis G, Bezieau S, Brenner H, Butterbach K, Caan BJ, Carlson CS, Casey G, Chang-Claude J, Conti DV, Curtis KR, Duggan D, Gallinger S, Haile RW, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA… | PLoS ONE | 2016 | PLCO |